
Share on:
The spine market accounted for $8.6 billion, or 18.2%, of the total orthopedic market in 2020. While the spine market suffered significant deferrals in the early months of the pandemic, it appears to be operating at or near historical volumes in the second half of 2021. Our latest spine review highlights the strategies that are driving current growth, initiatives of the largest companies, technologies recently deemed Breakthrough Devices by FDA and companies to watch.

RELATED ARTICLES
Kapstone Manufacturing to Integrate In-House DLyte Dry Electropolishing
Jun 04 2026 , Julie A. Vetalice
5 Packaging Validation Mistakes That Delay FDA Clearance
Jun 01 2026 , Matthew Emerick
Small Joint Implants: A New Era with Medureonâ„¢ Bionateâ„¢
Jun 01 2026 , dsm -firmenich



